PATENT CLAIM ANALYSIS

Application Number: 16279819
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-09
Patent Classification: ["514", "560000"]

Abstract:
The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.

Claim (Index 27):
The method of  claim 19 , wherein the effective dose is administered to the subject daily for a period of at least about 8 weeks.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 99.0
- Lexical Diversity: 1.13636
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15661374', '14730818', '15667683', '16198645', '14882662']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7331698201897755
- 35 USC 102 Novelty (BERT): 0.5666174870592804
- Combined Prediction Score: 0.716514586876726
- Mean Citation Score: 274.135856
- Max Citation Score: 409.79233
- Similarity Product: 254.8051847671425

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test